Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 6/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.38 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906819 | 0.87 | AR (0.43) | L3MBTL1KDM4EALDH1A1HPGDAR | |
| SCHEMBL13525484 | 0.82 | L3MBTL1 (0.47) | L3MBTL1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL18190631 | 0.82 | CA1 (0.39) | L3MBTL1KDM4EALDH1A1HPGDAR | |
| Cyanide SCHEMBL28871133 | 0.80 | ALDH1A1 (0.47) | L3MBTL1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL22904303 | 0.79 | AR (0.43) | L3MBTL1KDM4EALDH1A1ARPGR | |
| SCHEMBL186269 | 0.79 | ALDH1A1 (0.50) | L3MBTL1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL7868327 | 0.79 | AR (0.46) | ARPGRSLC22A12 | |
| SCHEMBL163604 | 0.79 | SLC22A12 (0.38) | KDM4EALDH1A1HSD17B10SLC22A12GAA | |
| SCHEMBL28248522 | 0.79 | HSD11B1 (0.35) | L3MBTL1KDM4EALDH1A1HSD17B10AR | |
| SCHEMBL27176574 | 0.78 | L3MBTL1 (0.39) | L3MBTL1KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115677598-B | Preparation method for synthesizing pyrimidinedione compound | 南通常佑药业科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-109574877-B | Preparation method of 2-cyano-3-fluorobenzotrifluoride | 南京正荣医药化学有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| CN-122076474-A | Halogen-modified supported noble metal catalyst and application thereof in synthesis of oxaragroli key intermediate | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| EP-4651866-A1 | HYDRAZONYL SULTONES AND USES THEREOF | The Research Foundation for The State University of New York (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12435040-B2 | 1,3-substituted cyclobutyl derivatives and uses thereof | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-10-07 | — | — | US | disclosed |
| US-12365655-B2 | Compounds | CTXT PTY LTD (AU) | 2025-07-22 | — | — | US | disclosed |
| CN-112334466-B | Compounds of formula (I) | CTXT私人有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-116603560-B | Palladium-loaded carbon nitride and application thereof in photocatalytic reduction of oxarogalli intermediate | 福州大学 | 2025-04-22 | — | — | CN | disclosed |
| EP-4031533-B1 | PROCESS FOR PREPARING ELAGOLIX SODIUM AND INTERMEDIATES THEREOF | SCINOPHARM TAIWAN LTD (TW) | 2025-01-01 | — | — | EP | disclosed |
| WO-2000003991-A1 | QUINOLINE DERIVATIVES | ACTIVE BIOTECH AB (SE) | 2000-01-27 | — | — | WO | disclosed |
| WO-1999055678-A1 | QUINOLINE DERIVATIVES | ACTIVE BIOTECH AB (SE) | 1999-11-04 | — | — | WO | disclosed |
| US-5942538-A | HALOBENZAMIDOXIME DERIVATIVE USED AS NONTOXIC FUNGICIDE | NIPPON SODA CO., LTD. (JP) | 1999-08-24 | — | — | US | disclosed |
| US-5874579-A | Insecticidal substituted-2.4-diaminoquinazolines related applications | FMC CORPORATION (US) | 1999-02-23 | — | — | US | disclosed |
| US-5847005-A | Benzamidoxime derivatives, process production thereof, and agrohorticultural bactericide | NIPPON SODA CO., LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
| CN-1170404-A | Benzamidoxime derivative, process for production thereof, and agrohoricultural bactericide | NIPPON SODA CO (JP) | 1998-01-14 | — | — | CN | disclosed |
| EP-0805148-A1 | BENZAMIDOXIME DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND AGROHORTICULTURAL BACTERICIDE | NIPPON SODA CO., LTD. (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5616718-A | USEFUL FOR MAKING 2,4-DIAMINOQUINAZOLINES; INSECTICIDES | FMC CORPORATION (US) | 1997-04-01 | — | — | US | disclosed |
| US-5534518-A | Insecticidal substituted-2,4-diaminoquinazolines | FMC CORPORATION (US) | 1996-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435040-B2 | 1,3-substituted cyclobutyl derivatives and uses thereof | TRPV1, TRPV3, TRPV2 | L3MBTL1 4704/4885KDM4E 4562/4885ALDH1A1 1031/4885 |
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | L3MBTL1 3817/4885KDM4E 800/4885ALDH1A1 1864/4885 |
| US-12365655-B2 | Compounds | SLC10A1, ABCB11, PCSK9 | L3MBTL1 4863/4885KDM4E 4009/4885ALDH1A1 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.